Đang chuẩn bị liên kết để tải về tài liệu:
Cardio-toxicity among patients with sarcoma: A cardio-oncology registry

Chemotherapy induced cardio-toxicity has been recognized as a serious side effect since the first introduction to anthracyclines (ANT). Cardio-toxicity among patients with breast cancer is well studied but the impact on patients with sarcoma is limited, even though they are exposed to higher ANT doses. | Cardio-toxicity among patients with sarcoma A cardio-oncology registry